Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Dow
Baxter
Mallinckrodt
Express Scripts

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

DrugPatentWatch Database Updates: New Patent Additions

See Plans and Pricing

« Back to Dashboard

DrugPatentWatch Database Updates: New Patent Additions

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.
Glossary
Applicant Tradename Generic Name Dosage NDA Number Approval Date Type RLD Patent No. Product Substance Delist Requested Patent Expiration Date Submitted Usecode Patented / Exclusive Use
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION 021660 001 Jan 7, 2005 RX Yes   Start Trial   Start Trial 2013-10-02 U-1434 TREATMENT OF PANCREATIC CANCER
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION 021660 001 Jan 7, 2005 RX Yes   Start Trial   Start Trial
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION 021660 001 Jan 7, 2005 RX Yes   Start Trial Y   Start Trial 2010-11-12 U-1092 TREATMENT OF BREAST CANCER
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION 021660 001 Jan 7, 2005 RX Yes   Start Trial Y   Start Trial 2010-11-12 U-1290 TREATMENT OF LUNG CANCER
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION 021660 001 Jan 7, 2005 RX Yes   Start Trial Y   Start Trial 2010-11-12 U-1434 TREATMENT OF PANCREATIC CANCER
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION 021660 001 Jan 7, 2005 RX Yes   Start Trial   Start Trial
Abraxis Bioscience ABRAXANE paclitaxel FOR SUSPENSION 021660 001 Jan 7, 2005 RX Yes   Start Trial   Start Trial 2011-04-15 U-1117 TREATMENT OF BREAST CANCER
>Applicant >Tradename >Generic Name >Dosage >NDA >Number >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Requested >Patent Expiration >Date Submitted >Usecode >Patented / Exclusive Use

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
McKinsey
Dow
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews